Table 3.
Clinical and treatment-related characteristics of HIV-positive adults using ART at hospitals of Kembata zone and Tembaro special district in Central Ethiopia from 1 January 2010 to 31 December 2020 (n = 432).
| Variables | Categories | Number (n) | Percent (%) |
|---|---|---|---|
| Body Mass Index | Underweight | 93 | 21.5 |
| Normal | 268 | 62.0 | |
| Over/obese | 71 | 16.4 | |
| Functional status | Working | 378 | 87.5 |
| Ambulatory | 50 | 11.6 | |
| Bedridden | 4 | 0.9 | |
| CD4 count in mm3 | ≤200 cells | 91 | 21.1 |
| 200–350 cells | 104 | 24.1 | |
| ≥350 cells | 237 | 55.9 | |
| Isoniazid therapy | Yes | 364 | 84.3 |
| No | 68 | 15.7 | |
| CPT | Yes | 328 | 75.9 |
| No | 104 | 24.1 | |
| Opportunistic infection (OI) | Yes | 230 | 53.2 |
| No | 202 | 46.8 | |
| OI Types | Zoster | 47 | 10.9 |
| Pneumonia | 85 | 19.8 | |
| Tuberculosis | 103 | 23.8 | |
| Time started | Same day | 101 | 23.4 |
| Within 2 weeks | 130 | 30.1 | |
| Within 4 weeks | 77 | 17.8 | |
| More than 4 weeks | 124 | 28.7 | |
| Types of regimen | 1C | 65 | 15.0 |
| 1D | 32 | 7.4 | |
| 1E | 172 | 39.8 | |
| 1F | 35 | 8.1 | |
| 1 J | 120 | 27.8 | |
| Other | 8 | 1.8 | |
| Number of regimen | One | 357 | 82.6 |
| Two | 75 | 17.4 | |
| Drug side effect | Yes | 103 | 23.8 |
| No | 329 | 76.2 | |
| Follow-up type | Routine | 266 | 61.6 |
| ASM | 166 | 38.4 | |
| Viral load | <1,000 | 245 | 56.7 |
| ≥1,000 | 34 | 7.9 | |
| Not done | 153 | 35.4 | |
| LTFU | Yes | 172 | 39.8 |
| No | 260 | 60.2 |
1C = AZT + 3tc + nvp, 1D = AZT + 3tc + efv, 1E = tdf + 3tc + efv, 1F = tdf + 3tc + nvp, 1 J = tdf + 3tc + dtg. 1C, 1E, and 1J were single or one fixed tablet and 1D, 1F, 2F, 2G were double or two fixed tablets.